Brief: Rubicon Research Says USFDA Issues Form 483 With 1 Observation To Co's Satara Facility
09/10/2026 16:26
BRIEF-Rubicon Research Says USFDA Issues Form 483 With 1 Observation To Co's Satara Facility Oct 9 (Reuters) - Rubicon Research Limited RUBI.NS:
RUBICON RESEARCH - US FDA ISSUES FORM 483 WITH 1 OBSERVATION TO CO'S SATARA FACILITY
Source text: ID:nNSE9fr0t7
Further company coverage: RUBI.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Rubicon Research
See all newsBrief: Rubicon Research Says USFDA Issues Form 483 With 1 Observation To Co's Satara Facility
Brief: General Atlantic Sells 13 Million Shares Of Rubicon Research Via Bulk Deal
India's Rubicon Research rises on quarterly profit, revenue jump
Brief: Rubicon Research June-Quarter Consol Net Profit 847.8 Million Rupees
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig